Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FPRX

Five Prime Therapeutics (FPRX) Stock Price, News & Analysis

Five Prime Therapeutics logo

About Five Prime Therapeutics Stock (NASDAQ:FPRX)

Advanced Chart

Key Stats

Today's Range
$38.00
$38.00
50-Day Range
$37.65
$38.00
52-Week Range
$2.61
$38.90
Volume
N/A
Average Volume
1.98 million shs
Market Capitalization
$1.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FPRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Five Prime Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FPRX Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
CMMB Chemomab Therapeutics Ltd.
What Is The Prime Rate Today?
See More Headlines

FPRX Stock Analysis - Frequently Asked Questions

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) issued its earnings results on Friday, November, 6th. The biotechnology company reported ($0.74) earnings per share for the quarter, missing analysts' consensus estimates of ($0.60) by $0.14. The biotechnology company earned $2.05 million during the quarter, compared to analysts' expectations of $3.50 million. Five Prime Therapeutics had a negative trailing twelve-month return on equity of 75.84% and a negative net margin of 554.71%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Five Prime Therapeutics investors own include Bristol Myers Squibb (BMY), Gilead Sciences (GILD), OPKO Health (OPK), Pfizer (PFE), Nektar Therapeutics (NKTR), Advanced Micro Devices (AMD) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
11/06/2020
Today
7/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FPRX
CIK
1175505
Fax
N/A
Employees
87
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($3.92)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$137.20 million
Net Margins
-554.71%
Pretax Margin
N/A
Return on Equity
-75.84%
Return on Assets
-49.08%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.35
Quick Ratio
5.35

Sales & Book Value

Annual Sales
$14.87 million
Price / Sales
119.01
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.13 per share
Price / Book
9.20

Miscellaneous

Outstanding Shares
46,572,000
Free Float
N/A
Market Cap
$1.77 billion
Optionable
Optionable
Beta
4.40
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:FPRX) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners